As Part of ‘Operation Nasal Vaccine’ to Counter COVID-19 Spread, ACM-001 Booster Vaccine Administered to First Subject in Phase 1 Safety and Immunogenicity Trial
ACM Biolabs, a biotechnology company with operations in Singapore, Switzerland and Australia, focusing on the development of next generation vaccines...
